Tralokinumab Disease Interactions
There are 3 disease interactions with tralokinumab.
Tralokinumab (applies to tralokinumab) live vaccines
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Vaccination
Tralokinumab may alter patient immunity and increase risk of infection after administration of live vaccines. Before starting this drug, complete all age-appropriate vaccinations according to current guidelines. Do not use live vaccines in patients treated tralokinumab.
References
- (2022) "Product Information. Adbry (tralokinumab)." Leo Pharma Inc
Tralokinumab (applies to tralokinumab) parasitic infections
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral
Tralokinumab may influence the immune response against helminth infections by inhibiting interleukin 13 (IL-13) signaling. Patients with preexisting helminth infections should be treated before initiating treatment with this drug. If patients become infected while already in treatment and do not respond to antihelminth treatment, discontinue this drug until infection resolves.
References
- (2022) "Product Information. Adbry (tralokinumab)." Leo Pharma Inc
Tralokinumab (applies to tralokinumab) visual disturbances
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Visual Defect/Disturbance
Conjunctivitis and keratitis occurred more frequently in patients with atopic dermatitis who received tralokinmab, being conjunctivitis the most frequently reported eye disorder. Patients should report new onset or worsening of any existing eye symptoms to their healthcare provider.
References
- (2022) "Product Information. Adbry (tralokinumab)." Leo Pharma Inc
Tralokinumab drug interactions
There are 167 drug interactions with tralokinumab.
More about tralokinumab
- tralokinumab consumer information
- Check interactions
- Compare alternatives
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.